Paolo Grassi, MD, is currently the Senior Clinical Development Lead in Oncology at Bayer Pharmaceuticals, a position held since 2023. Previously, from 2020 to 2023, they served as a Clinical Development Leader focused on Early Development in Portfolio Oncogenic Signaling at Bayer. Paolo's experience includes clinical fellowships at The Royal Marsden NHS Foundation Trust and the Catalan Institute of Oncology, along with significant work at the IRCCS Istituto Nazionale dei Tumori Foundation in Milan, Italy. They earned their MD in Medical Oncology from Università degli Studi di Roma 'La Sapienza' and completed a Certificate of Advanced Studies in Pharmaceutical Medicine at the European Center of Pharmaceutical Medicine in 2023.
This person is not in the org chart
This person is not in any teams
This person is not in any offices